Over a year of follow-up, the bleeding episodes decreased and factor VII infusion was needed only once during the first 6 months after starting the treatment of SLE, and in the second 6 months she did not need factor VII infusion. The gene discussed is F7; the disease is systemic lupus erythematosus.